ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Comparing The Immunologic Responses Between Kidney Transplant Recipients Receiving Standard Immunosuppression And CNI Reduction After Two Doses Of ChAdOx-1 And A Booster Dose BNT162b2

    S. Phirom1, T. Kitrungphaiboon2, W. Jantarabenjakul2, Y. Avihingsanon2, W. Prasithsirikul3, J. Vanichanan4, P. Hansasuta5, N. Townamchai6

    1Nephrology division, Department of medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand, 2King Chulalongkorn Memorial Hospital, Bangkok, Thailand, 3Bamrasnaradura infectious disease institute, Bangkok, Thailand, 4Infectious diseases, Department of medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand, 5Department of Microbiology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand, 6Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand

    *Purpose: Immunosuppression can impair immunological responses after vaccination in kidney transplant recipients (KTR). However, little is known about the effect of the booster dose of…
  • 2022 American Transplant Congress

    Reproductive Counseling in Kidney Transplant: Patient Needs and Current Practices

    S. Rajagopal1, J. Ritchie2, D. Seidman3, Y. Srisengfa4, E. R. Perito5, D. Adey6, M. Sarkar7

    1Internal Medicine, Brookdale University Hospital, Brooklyn, NY, 2Obstetrics and Gynecology, St Luke's University Health Network, Bethlehem, PA, 3Obstetrics and Gynecology, University of California San Francisco, San Francisco, CA, 4University of California San Francisco, San Francisco, CA, 5Pediatric GI/Hepatology, University of California San Francisco, San Francisco, CA, 6Nephrology, University of California San Francisco, San Francisco, CA, 7GI/Hepatology, University of California San Francisco, San Francisco, CA

    *Purpose: Nearly 20% of female kidney transplant (KT) recipients are reproductive-aged. Early/unplanned pregnancies post-KT increase maternal and fetal risks, though data on reproductive counseling in…
  • 2022 American Transplant Congress

    Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for T2 Hepatocellular Carcinoma and May Allow for Decreased Mortality

    C. Durkin1, T. Bittermann1, D. E. Schaubel2

    1Gastroenterology, University of Pennsylvania, Philadelphia, PA, 2Biostatistics, University of Pennsylvania, Philadelphia, PA

    *Purpose: Prior studies have suggested that induction therapy leads to worse outcomes after liver transplantation (LT) for hepatocellular carcinoma (HCC). This study evaluated the impact…
  • 2022 American Transplant Congress

    Maribavir (MBV) versus Investigator-Assigned Therapy (IAT) for Refractory Cytomegalovirus (CMV) Infection (with or without Resistance) in Solid Organ Transplant (SOT) Recipients: Subgroup Safety Analysis of a Phase 3 Study

    R. M. La Hoz1, D. Florescu2, D. Kumar3, F. Saliba4, J. Gu5, A. Sundberg5

    1Univ. Texas Southwestern Medical Center, Dallas, TX, 2Univ. Nebraska Medical Center, Omaha, NE, 3Univ. Health Network, Toronto, ON, Canada, 4Univ. Paris Saclay, Paris, France, 5Takeda Development Center Americas, Inc., Lexington, MA

    *Purpose: In a Phase 3 study of MBV vs IAT (val/ganciclovir, foscarnet, or cidofovir) for refractory CMV infection (with/without resistance; R/R) in hematopoietic cell transplant…
  • 2022 American Transplant Congress

    Association of Native Kidney Disease with De Novo Cancer Development After Kidney Transplant

    Y. Caliskan1, D. Axelrod2, R. Li1, W. Cheungpasitporn3, M. Schnitzler1, M. McAdams DeMarco4, J. Ahn4, T. Alhamad5, H. Randall1, S. Bae4, D. Segev4, K. L. Lentine1

    1Saint Louis University, Saint Louis, MO, 2University of Iowa, Iowa City, IA, 3Mayo Clinic, Rochester, MN, 4John Hopkins University, Baltimore, MD, 5Washington University in Saint Louis, Saint Louis, MO

    *Purpose: Primary glomerulonephritis (GN) and congenital anomalies of the kidney and urinary tract (CAKUT) have been shown to be associated with cancer development in the…
  • 2022 American Transplant Congress

    Histocompatibility Findings in the First Xenotransplants from a Pig to Deceased Human Recipient

    M. Mangiola, V. Tatapudi, J. Stern, Z. Stewart Lewis, B. Lonze, N. Ali, R. Montgomery

    Transplant Institute, NYU Langone Transplant Institute, New York, NY

    *Purpose: Humans lack α-1,3-Gal (α-gal) epitopes, and naturally occurring α-gal antibodies (Abs) cause hyperacute rejection of porcine xenografts. We conducted 2 successful xenotransplants in brain-dead…
  • 2022 American Transplant Congress

    Donor Organ Utilization And Transplantation Outcomes In Donation After Circulatory Death Using Thoracoabdominal Normothermic Regional Perfusion

    M. Urban, S. Merani, N. W. Markin, A. Castleberry, J. Um

    University of Nebraska Medical Center, Omaha, NE

    *Purpose: Evidence suggests that in-situ reperfusion of abdominal organs with normothermic oxygenated blood in donation after circulatory death (DCD) provides superior post-transplantation outcomes in comparison…
  • 2022 American Transplant Congress

    Pre-Emptive Rituximab to Prevent Post Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Kidney Transplant Recipients with EBV DNAemia: A Case Series from the Pediatric Nephrology Research Consortium (PNRC)

    I. Ashoor1, S. Ranabothu2, S. Al-Akash3, A. Moudgil4, Y. Shi4, S. Kizilbash5, D. Puliyanda6, V. Dharnidharka7

    1LSU Health Sciences Center New Orleans, New Orleans, LA, 2Arkansas Children's Hospital, Little Rock, AR, 3Driscoll Children's Hospital, Corpus Christie, TX, 4Children's National Medical Center, Washington, DC, 5University of Minnesota Medical Center, Minneapolis, MN, 6Cedars-Sinai Medical Center, Los Angeles, CA, 7Washington University in St. Louis, St Louis, MO

    *Purpose: The use of Rituximab (RTX) to prevent PTLD in patients with EBV DNAemia is an established strategy in hematopoietic stem cell transplants, but with…
  • 2022 American Transplant Congress

    Gender Affects the Association Between Serum Creatinine Levels and Clinical Response to Terlipressin in Patients with Hepatorenal Syndrome Type of Acute Kidney Injury

    K. Jamil1, R. Frederick2, S. Pappas3

    1Hepatology, Mallinckrodt Pharmaceuticals, Clinton, NJ, 2Liver Disease/Hepatology & Transplant Hepatology, California Pacific Medical Center, San Francisco, CA, 3Orphan Therapeutics, LLC, Longboat Key, FL

    *Purpose: Hepatorenal syndrome (HRS)-acute kidney injury (AKI) is a rare and serious complication of cirrhosis, with serum creatinine (SCr) used diagnostically. Women generally have less…
  • 2022 American Transplant Congress

    Creating a Workflow for the Electronic Medical Record Allows Living Donor Liver Transplantation Programs to Track Candidates and Identify Areas for Optimization

    A. Liapakis1, R. Batra1, E. Cohen2, D. Haakinson1, M. Schilsky1, K. Ventura2, D. Mulligan1

    1Yale University School of Medicine, New Haven, CT, 2Yale New Haven Hospital, New Haven, CT

    *Purpose: To provide a pathway to increase living donor liver transplantation (LDLT) opportunities through creation of a simple workflow algorithm embedded within the EPIC electronic…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 190
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences